Alan D. Sobel - Feb 27, 2023 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Director
Signature
/s/ Kathleen P. Bloch attorney-in-fact for Alan D. Sobel
Stock symbol
CTSO
Transactions as of
Feb 27, 2023
Transactions value $
$0
Form type
4
Date filed
3/1/2023, 04:15 PM
Previous filing
Aug 12, 2022
Next filing
Jul 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Gift $0 +2K +2.52% $0.00 81.3K Feb 27, 2023 Direct F1, F2
transaction CTSO Common Stock Gift $0 -2K -100% $0.00* 0 Feb 27, 2023 Bernard Sobel Revocable Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the transfer of shares to the reporting person from the Bernard Sobel Revocable Trust (the "Trust"), for which the reporting person is a trustee and a named beneficiary.
F2 Includes (i) the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015 and (ii) 12,000 shares of common stock owned directly by the reporting person.